Original Article
A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis Beena Bansal, Shyam Bihari Bansal1, Ambrish Mithal2, Vijay Kher3, R. Marwaha4, Padam Singh5, Nasir Irfan6 Senior Consultant, Division of Endocrinology and Diabetes, 1Senior Consultant, 3Chairman, Kidney and Urology Institute, 2Chairman, Division of Endocrinology and Diabetes, Medanta, The Medicity, Gurgaon, 4Scientific Advisor, Institute of Life Sciences, 5Chief Statistical Advisor, Medanta Institute of Education and Research, Gurgaon, Haryana, 6Medical Officer, Chenab Hospital, Dulhasti Power Station, National Hydel Power Corporation Ltd., Kishtwar, Jammu and Kashmir, India
A B S T R A C T Background: Vitamin D deficiency is common in Indian patients with chronic kidney disease (CKD) on maintenance hemodialysis (MHD), but optimal dose of cholecalciferol is unclear. Materials and Methods: A total of 45 consenting patients were randomized to intervention and control groups. In the intervention group, patients (n = 35) with serum 25‑hydroxy vitamin D (25(OH)D)
A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis Beena Bansal, Shyam Bihari Bansal1, Ambrish Mithal2, Vijay Kher3, R. Marwaha4, Padam Singh5, Nasir Irfan6 Senior Consultant, Division of Endocrinology and Diabetes, 1Senior Consultant, 3Chairman, Kidney and Urology Institute, 2Chairman, Division of Endocrinology and Diabetes, Medanta, The Medicity, Gurgaon, 4Scientific Advisor, Institute of Life Sciences, 5Chief Statistical Advisor, Medanta Institute of Education and Research, Gurgaon, Haryana, 6Medical Officer, Chenab Hospital, Dulhasti Power Station, National Hydel Power Corporation Ltd., Kishtwar, Jammu and Kashmir, India
A B S T R A C T Background: Vitamin D deficiency is common in Indian patients with chronic kidney disease (CKD) on maintenance hemodialysis (MHD), but optimal dose of cholecalciferol is unclear. Materials and Methods: A total of 45 consenting patients were randomized to intervention and control groups. In the intervention group, patients (n = 35) with serum 25‑hydroxy vitamin D (25(OH)D)
